Patent details

Basic Information

Publication number:

EP2353611

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP111652046

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease

French Title of Invention:

Conjugués de médicaments et leur utilisation pour traiter le cancer, maladie auto-immune ou maladie infectieuse

German Title of Invention:

Arzneimittelkonjugate und deren Verwendung zur Behandlung von Krebs, einer Autoimmunerkrankung oder einer Infektionskrankheit

SPC Number:

Dates

Filing date:

31/07/2003

Grant date:

13/05/2015

EP Publication Date:

13/05/2015

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

10/08/2011

EP B1 Publication Date:

13/05/2015

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

31/07/2015

Expiration date:

31/07/2023

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

31/07/2003

 

 

Name:

Seattle Genetics Inc.

Address:

21823 30th Drive, S.E., Bothell, WA 98021, United States (US)

Inventor

1

Name:

Doronina Svetlana

Address:

United States (US)

2

Name:

Toki Brian E.

Address:

United States (US)

3

Name:

Senter Peter D.

Address:

United States (US)

Priority

Priority Number:

400403 P

Priority Date:

31/07/2002

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 47/48;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages